Trial site
Zentralklinik Bad Berka GmbH
- 19running trials
- 12closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Lung cancer14 trials
- Idiopathic pulmonary fibrosis7 trials
- Heart failure3 trials
- Familial hypercholesterolaemia2 trials
- Neuroendocrine tumours2 trials
- Obesity2 trials
- COPD1 trial
- Coronary artery disease1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 323 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Completed11 trials
- Recruiting11 trials
- Active, not recruiting7 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC5 trials
- AstraZeneca3 trials
- AbbVie2 trials
- Pfizer2 trials
- United Therapeutics2 trials
- and 17 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
Active, not recruiting
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer7 recruiting
- Heart failure2 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Obesity2 recruiting
- COPD1 recruiting
Closed trials
Active, not recruiting
Completed
CABONEN – a phase II trial of Cabozantinib in patients with advanced, low proliferative NEN G3
Completed
Completed
Withdrawn
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026